Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Braz. j. med. biol. res ; 53(10): e10204, 2020. graf
Article in English | LILACS, ColecionaSUS | ID: biblio-1132473

ABSTRACT

Several isatin derivatives have shown important biological activities, which have attracted interest from researchers. For this reason, the present study aimed to evaluate the anti-inflammatory and antinociceptive effects of the isatin derivative (Z)-2-(5-chloro-2-oxoindolin-3-ylidene)-N-phenyl-hydrazinecarbothioamide (COPHCT) in mice. Three doses of this compound were tested: 1.0, 2.5, and 5.0 mg/kg. The anti-inflammatory activity was assessed using the carrageenan-induced paw edema model and the zymosan-induced air pouch model. The evaluation of the antinociceptive effect was performed through the formalin test and the acetic acid-induced abdominal writhing test. The paw edema assay demonstrated that all doses of the compound showed a significant reduction of the edema in the second hour evaluated, but a better response was observed in the fourth hour. The zymosan-induced air pouch model indicated that the compound, in all doses, significantly reduced leukocyte migration and total protein concentration levels. In the formalin test, the doses 1.0, 2.5, and 5.0 mg/kg of COPHCT showed activity only in the second phase, with reduction in paw pain time of 73.61, 79.46, and 73.85%, respectively. The number of abdominal writhings decreased with the increasing dose, but only 5.0 mg/kg COPHCT exhibited a significant response, with a reduction of 24.88%. These results demonstrated the ability of this compound to interfere in the anti-inflammatory activity of edema, vascular permeability, and cell migration. In addition, its possible antinociceptive effect may be related to the dose used.


Subject(s)
Animals , Male , Female , Rats , Analgesics/pharmacology , Isatin/pharmacology , Anti-Inflammatory Agents/pharmacology , Plant Extracts , Carrageenan , Edema
2.
Rev. bras. plantas med ; 12(4): 401-405, out.-dez. 2010. tab
Article in Portuguese | LILACS | ID: lil-578979

ABSTRACT

O presente trabalho objetivou avaliar a calagem e adubação orgânica na produção de biomassa e óleo essencial em Lippia citriodora Kunth. O delineamento experimental utilizado constou de fatorial 7 x 2, sendo sete tratamentos (testemunha; adição de sulfato de Ca e Mg; calcário dolomítico; silicato de Ca e Mg; sulfato de Ca e Mg + esterco de curral; calcário dolomítico + esterco de curral; silicato de Ca e Mg + esterco de curral) e duas épocas de colheita, com quatro repetições, inteiramente casualizado (DIC). Verificou-se que a correção do solo mostrou-se prática necessária para o desenvolvimento da Lippia citriodora. Independentemente da época de colheita, a produção de massa fresca e seca foi maior com a aplicação do esterco de curral (32 t ha-1), no entanto, isso não refletiu em maior rendimento de óleo essencial.


The present work aimed to evaluate the effect of liming and bovine fertilization on Lippia citriodora Kunth phytomass and essential oil production. The experimental design was completely randomized with seven treatments (control; Ca and Mg sulfate; limestone; Ca and Mg silicate; Ca and Mg sulfate + manure; limestone + manure; Ca and Mg silicate + manure) and two harvest seasons, with four replicates. Soil adjustment showed to be a necessary procedure for Lippia citriodora development. Independently of the harvest season, fresh and dry matter yields were higher under treatments with bovine manure (32 t ha-1); however, no effect of treatments was observed on essential oil concentration.


Subject(s)
Biomass , Lippia , Oils, Volatile , Soil Treatment/analysis , Soil Treatment/methods , Manure , Organic Agriculture , Calcareous Soils/analysis
3.
Braz. j. microbiol ; 40(2): 333-338, Apr.-June 2009. graf, tab
Article in English | LILACS, SES-SP | ID: lil-520219

ABSTRACT

No effective vaccine or immunotherapy is presently available for patients with the hemolytic uremic syndrome (HUS) induced by Shiga-like toxin (Stx) producedbyenterohaemorragic Escherichia coli (EHEC) strains, such as those belonging to the O157:H7 serotype. In this work we evaluated the performance of Bacillus subtilis strains, a harmless spore former gram-positive bacterium species, as a vaccine vehicle for the expression of Stx2B subunit (Stx2B). A recombinant B. subtilis vaccine strain expressing Stx2B under the control of a stress inducible promoter was delivered to BALB/c mice via oral, nasal or subcutaneous routes using both vegetative cells and spores. Mice immunized with vegetative cells by the oral route developed low but specific anti-Stx2B serum IgG and fecal IgA responses while mice immunized with recombinant spores developed anti-Stx2B responses only after administration via the parenteral route. Nonetheless, serum anti-Stx2B antibodies raised in mice immunized with the recombinant B. subtilis strain did not inhibit the toxic effects of the native toxin, both under in vitro and in vivo conditions, suggesting that either the quantity or the quality of the induced immune response did not support an effective neutralization of Stx2 produced by EHEC strains.


Até o presente o momento, não há vacina ou imunoterapia disponível para pacientes com Síndrome Hemolítica Urêmica (SHU) induzida pela toxina Shiga-like (Stx) produzida por linhagens de Escherichia coli entero-hemorragica (EHEC), tais como as pertencentes ao sorotipo O157:H7. Neste trabalho, avaliamos a performance de Bacillus subtilis, uma espécie bacteriana gram-positiva não-patogênica formadora de esporos, como veículo vacinal para a expressão da subunidade B da Stx2B (Stx2B). Uma linhagem vacinal recombinante de B. subtilis expressando Stx2B, sob o controle de um promoter induzível por estresse, foi administrada a camundongos BALB/c por via oral, nasal ou subcutânea usando células vegetativas e esporos. Camundongos imunizados com células vegetativas e esporos pela via oral desenvolveram títulos anti-Stx2B baixos, mas específicos, de IgG sérico e IgA fecal, enquanto camundongos imunizados com esporos recombinates desenvolveram resposta anti-Stx2B apenas após a administração pela via parenteral. No entanto, anticorpos produzidos em camundongos imunizados com a linhagem recombinante de B. subtilis não inibiram os efeitos tóxicos da toxina nativa em condições in vitro e in vivo, sugerindo que a quantidade e/ou a qualidade da resposta imune gerada não suportam uma neutralização efetiva da Stx2 produzidas por linhagens de EHEC.


Subject(s)
Animals , Mice , Enterohemorrhagic Escherichia coli , Antibodies, Bacterial/analysis , Bacillus subtilis/isolation & purification , In Vitro Techniques , Bacterial Vaccines , Mice , Spores, Bacterial , Methods , Serotyping , Methods
SELECTION OF CITATIONS
SEARCH DETAIL